TY  - GEN
AU  - Palomba,Stefano
AU  - Orio,Francesco
AU  - Russo,Tiziana
AU  - Falbo,Angela
AU  - Tolino,Achille
AU  - Manguso,Francesco
AU  - Nunziata,Vincenzo
AU  - Mastrantonio,Pasquale
AU  - Lombardi,Gaetano
AU  - Zullo,Fulvio
TI  - BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial
SN  - 0937-941X
PY  - 2006///0131
KW  - Administration, Oral
KW  - Aged
KW  - Alendronate
KW  - administration & dosage
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - Bone Resorption
KW  - prevention & control
KW  - Drug Combinations
KW  - Drug Therapy, Combination
KW  - Estrogens, Conjugated (USP)
KW  - Female
KW  - Genotype
KW  - Hormone Replacement Therapy
KW  - adverse effects
KW  - Humans
KW  - Medroxyprogesterone Acetate
KW  - Middle Aged
KW  - Osteoporosis, Postmenopausal
KW  - drug therapy
KW  - Prospective Studies
KW  - Raloxifene Hydrochloride
KW  - Receptors, Calcitriol
KW  - genetics
KW  - Selective Estrogen Receptor Modulators
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00198-004-1800-5
ER  -